atHeart Medical

📍 Baar, Switzerland🗓 Founded 2021👥 23 employees💰 Last funded 2020
atHeart Medical was founded to establish the first transcatheter septal occluder with a metal-free frame, as the new standard of care for atrial septal defects. We have initiated the U.S. FDA approved ASCENT-ASD pivotal trial in the United States and internationally to demonstrate the safety and efficacy of our reSept ASD Occluder for treating patients with clinically significant, isolated ASD. Our name embeds our values: in everything we do, we have clinical excellence and patients at heart.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in atHeart Medical?
atHeart Medical has 1 investors on record on gritt.io, including 1 early-stage backers.
When did atHeart Medical last raise funding?
The most recent investment in atHeart Medical recorded on gritt.io was in 2020.
When was atHeart Medical founded?
atHeart Medical was founded in 2021.
What industry is atHeart Medical in?
atHeart Medical operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is atHeart Medical based?
atHeart Medical is headquartered in Baar, Switzerland.